Nielsen J L
Neuropsychobiology. 1980;6(1):48-51. doi: 10.1159/000117732.
In 21 patients suffering from endogenous depression and given nortriptyline 150 mg/day for 4 weeks in a once-a-day dosage an electrocardiographic study was made with ECG recordings at different times during the treatment. At the same time the plasma concentration of nortriptyline was determined. During the treatment the heart rate increased significantly, both at the minimum and the maximum concentration of nortriptyline. At the maximum concentration the PQ interval increased significantly. None of the patients developed an A-V block. 3 patients developed extrasystoles. None of the patients had severe subjective symptoms. All finished the trial as planned. There was no correlation between the plasma concentration of nortriptyline and the increase in heart rate. The trial revealed no serious cardiac influence during treatment with nortriptyline in a once-a-day dosage.
对21例内源性抑郁症患者给予去甲替林,剂量为150毫克/天,每日一次,持续4周,并在治疗期间的不同时间进行心电图记录以进行心电图研究。同时测定去甲替林的血浆浓度。治疗期间,在去甲替林的最低和最高浓度时,心率均显著增加。在最高浓度时,PQ间期显著延长。无一例患者发生房室传导阻滞。3例患者出现期前收缩。无一例患者有严重的主观症状。所有患者均按计划完成试验。去甲替林的血浆浓度与心率增加之间无相关性。该试验表明,每日一次剂量的去甲替林治疗期间对心脏无严重影响。